POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW)
Substance profile for UNII QD923V64H3, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- QD923V64H3
- Preferred term
- POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW)
- Registry number
- 26780-50-7
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- Polymer substance not supported
Chemical And Database Identifiers#
- RxCUI
- 1309728
- PubChem
- 0
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| RxNorm | 1309728 | https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1309728 |
| FDA Substance Registration System | QD923V64H3 | https://precision.fda.gov/uniisearch/srs/unii/QD923V64H3 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW) | INACTIVE INGREDIENT | QD923V64H3 | BYDUREON (EXENATIDE) INJECTION, SUSPENSION, EXTENDED RELEASE BYDUREON (EXENATIDE) KIT [ASTRAZENECA PHARMACEUTICALS LP] | 11 | |
| poly(dl-lactic-co-glycolic acid), (50:50; 63000 mw) | INACTIVE INGREDIENT | QD923V64H3 | BYDUREON (EXENATIDE) KIT [AMYLIN PHARMACEUTICALS, LLC] | 9 | |
| POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW) | INACTIVE INGREDIENT | QD923V64H3 | SIGNIFOR LAR (PASIREOTIDE) KIT [NOVARTIS PHARMACEUTICALS CORPORATION] | 2 |